• Skip to primary navigation
  • Skip to main content
  • Skip to footer
Home
  • LinkedIn
  • Twitter

  • About Us
    • Overview
    • Executive Committee
    • Board Of Directors
    • Partners
  • Science
    • Overview
    • Approach
    • Technology
      • Our Technology
      • TIM
      • shRNA
      • shARC Platform
    • Scientific Publications
  • Pipeline
  • Newsroom
    • Press Releases
    • Events
    • Media Center
  • Investors
    • Overview
    • Analyst Coverage
    • Corporate Governance
    • Regulated Information
    • Shareholders Information
    • Shareholders Meeting
  • Careers
  • Contact Us

Celyad Announces April 2019 Investor Conference Schedule

April 1, 2019 By Celyad

Mont-Saint-Guibert, Belgium – Celyad (Euronext Brussels and Paris, and Nasdaq: CYAD), a clinical-stage biopharmaceutical company focused on the development of CAR-T cell-based therapies, today announced that management plans to present at four investor conferences in April 2019.


Conference details:William Blair 3rd Annual Late-Stage Therapeutics ConferenceDate: Thursday, April 4, 2019Location: New York, New York Jefferies 6th Annual IO Cell Therapy SummitDate: Friday, April 5, 2019Presentation Time: 3:45 p.m. EDT     Location: Boston, Massachusetts HC Wainwright Global Life Sciences ConferenceDate:Monday, April 8, 2019Presentation Time: 10:10 a.m. CESTLocation:London, United KingdomWebcast: Celyad’s website, under Events & Webcasts section Kempen Life Science ConferenceDate:Tuesday, April 16, 2019Presentation Time: 2.55 p.m. CESTLocation:Amsterdam, Netherlands

Download press release(s)
Communiqué de presse
Press Release

Filed Under: Corporate, Non-regulated

Footer

Celyad Oncology

Celyad Oncology Logo
  • About
  • Science
  • Pipeline
  • Newsroom
  • Investors
  • Contact Us
  • LinkedIn
  • Twitter

Copyright © 2020 All Rights Reserved.

  • Cookie Policy |
  • Privacy Policy |
  • Terms of Use